Circulating progenitor cells: a comparison of patients with glioblastoma or meningioma

Circulating Endothelial Cells and Circulating Progenitor Cells in Breast Cancer: Relationship to Endothelial Damage/Dysfunction/ Apoptosis, Clinicopathologic Factors, and the Nottingham Prognostic Index

(2015) Patrick K.Y. Goon et al.   NEOPLASIA

Antiangiogenic Therapy for Glioblastoma

(2012) Elizabeth R. Gerstner et al.   CANCER JOURNAL

Prognostic Significance of Angiogenesis in Relation to Ki-67, p-53, p-27, and bcl-2 Expression in Embryonal Tumors

(2012) Maria Moschovi et al.   PEDIATRIC NEUROSURGERY

The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma

(2011) J. J. Vredenburgh et al.   CLINICAL CANCER RESEARCH

Influence of BMI on Level of Circulating Progenitor Cells

(2011) Charles F. Bellows et al.   Obesity

Circulating endothelial progenitor cells in malignant gliomas

(2009) Neysan Rafat et al.   JOURNAL OF NEUROSURGERY

SURROGATE MARKERS PREDICT ANGIOGENIC POTENTIAL AND SURVIVAL IN PATIENTS WITH GLIOBLASTOMA MULTIFORME

(2009) Jeffrey P. Greenfield et al.   NEUROSURGERY

Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?

(2007) W Wojakowski et al.   HEART